in Dr H. B. Hewitt's WHT mouse colony at the Gray Laboratory. An in vitro cell culture was established from one of these tumours and, after a period of adaptation to the in vitro growth conditions, the cells of this new line, denoted Fib/T, would form colonies with a plating efficiency of 60-90% when plated on to a "feeder layer " of cells killed by radiation. Subcutaneous injection of 105 or more of these cultured cells into a mouse resulted in a palpable tumour within 7 to 14 days. This tumour was excised when it had reached a diameter of about 8 mm (mean of 3 dimensions) and approximately 1-mm3 pieces of tumour were implanted s.c. by trocar on to the chests of up to 100 male WHT mice to provide the experimental tumours. The cells of these tumours, if plated in vitro in appropriate conditions, form colonies with a plating efficiency, like the parental cell line, of 60 to 9000.
When the experimental tumours had reached a mean diameter of 8 mm they were distributed randomly between control groups and groups receiving combinations of heat, Ro-07-0582 and X-rays (Table) . Tumours were irradiated in air with single doses of 240 kV X-rays as described by Fowler et al. (1975) . The drug, at a dose of 1 mg/g body wt., was administered by i.p. injection immediately after irradiation, and heating was begun The colonies were then stained and counted, and the surviving fractions calculated.
The results are shown in Fig. 1 . The surviving fraction is plotted against X-ray dose for each of 4 treatment groups. Each point represents the pooled results from between 2 and 4 tumours (see Table) . Error bars are the standard errors of the mean. The surviving fractions for treatments with X-rays plus drug (without heat) and for X-rays plus heat (without drug) were not significantly different from those for treatments with X-rays alone, although in almost all cases the points fell x, X-rays only; A, X-rays followed by 1 h heating at 40 5°C (tumour core); 0, X-rays followed by i.p. injection of (1 mg/g); 0, X-rays followed by Ro-07-0582 (1 mg/g) and heat (1 h at 40.5°C).
Each point represents the pooled results from between 2 and 4 tumours (see Table) and the bars show the s.e. mean.
below the X-ray survival curve in Fig. 1 . By contrast, the curve for the combined treatment of X-rays followed by heat plus the drug was significantly lower than those for the other treatments. The addition of the heat plus the drug after irradiation reduced the X-ray dose necessary to give a surviving fraction of 10-2 by 780 rad. Fig. 1 shows that all the curves were parallel over the range of X-ray doses used, from 0 to 2500 rad, implying that the combination of heat plus the drug was just as effective in killing cells in the un-irradiated tumours as in killing those surviving different X-ray doses. This is probably due to the high hypoxic fraction in this tumour, at least 50% (McNally, unpublished data) . Recent experiments with this tumour have shown that the maximum radiosensitization by Ro-07-0582 given prior to irradiation is not achieved until 45-60 min after an i.p. injection, and persists at a maximum for a further hour (McNally, unpublished data) . In view of this, in a second experiment, tumours were heated for 1, 2 or 4 h with or without an injection of Ro-07-0582. In this experiment tumours were not irradiated first, since the additional fraction of cells killed by heat plus the drug was very similar at all X-ray doses (Fig. 1) .
The fraction of cells surviving after heat alone, Ro-07-0582 alone, or a combination of the two, is plotted against time of heating after injection of the drug in Fig. 2 . The values obtained for individual tumours are shown as separate points. In the case of heat alone, there was no significant increase in cell killing with time. Contact with the drug alone for 1 or 2 h had no effect, but after 4 h the surviving fraction was reduced to about 0-5. The effect of the combined treatment of heat plus the drug did not change with time after 1 h of heating, although at 1 and 2 h it was considerably more effective than either treatment alone or the sum of the two, implying interaction between the two forms of treatment. This means an enhancement of the cytotoxic action of Ro-07-0582, since heat itself had no effect. By 4 h, however, the cytotoxic action of the drug alone had become significant. This meant that the combined effect of the drug and heat at 4 h was no different from the sum of the effects of the two acting independently. The absence of any further interaction at 4 h is probably a reflection of the falling concentration of Ro-07-0582 in the tumour (see below). The response of the tumours to heat alone is consistent with the findings of Har-Kedar (personal communication) and of Palzer and Heidelberger (1973) , who showed that temperatures below 42°C are not effective in killing mammalian cells in vitro. The results shown in Figs. 1 and 2 clearly demonstrate that, while the heat in itself had no effect, it greatly enhanced the cytotoxic action of Ro-07-0582 on the hypoxic tumour cells. The enhancement seen at 1 h is in good agreement with the in vitro results of Stratford and Adams (1977) . Increasing the time of heating from 1 to 4 h, however, did not increase this enhancement. This is in apparent contrast to the results of Strat-ford and Adams (1977) who found that, over the same time period, the cytotoxic effect of Ro-07-0582 at a concentration of 0-2 mg/ml on hypoxic cells maintained at 41°C in vitro was increased by a factor of 100.
A possible explanation for this discrepancy is as follows. An artificially high value for cell survival in the tumour would result if those cells destined to be non-survivors because of the treatment were selectively removed, either before the tumour was excised or during the preparation of the cell suspension. The mean cell yield per gram of tumour was approximately 50% less after 4 h treatment in the presence of the drug than after any of the other treatments. However, this difference was not significant and, since this tumour has such a high hypoxic fraction, this explanation probably cannot explain the discrepancy with the in vitro results. A second and more likely explanation for the apparent discrepancies with the in vitro results, as indicated previously, is that by 1P5 to 2 h after injection of the drug, its concentration in the tumour was probably too low to expect further significant interaction with the hyperthermia.
Bleehen, Honess and Morgan (1977) have been carrying out similar experiments to us, using the EMT6 tumour, in which they also assay cell survival in vitro after treatment in vivo. They did not irradiate the tumours before heating. They obtained tumour core temperatures in the range 40 5 to 43°C. A tumour temperature of 40 5°C for 1 h produced the same amount of cell killing in the EMT6 tumour as it did in the Fib/T tumour. However, in contrast to our results, Bleehen et al. (1977) found little interaction of the hyperthermia with Ro-07-0582 (used at the same concentration as in the present experiments) below a tumour core temperature of about 42-5WC. This difference may reflect the different hypoxic fractions in the two tumours, > 50% in the Fib/T tumour, about 30% in the EMT6 tumour.
In summary, an appreciable enhancement of the cytotoxic action of Ro-07-0582 on hypoxic tumour cells in vivo was observed within 1 h of heating at 40*5°C, a temperature which, by itself, had no effect. This enhancement was not increased by increasing the time of heating to 4 h. In contrast, if it were possible to make use of the interaction of mild hyperthermia and Ro-07-0582 in the treatment of human tumours, one might expect that increasing the duration of the hyperthermia would greatly enhance the drug's cytotoxic action in these tumours. This is because of its much longer half-life in man than in the mouse (Gray et al., 1976) . In this respect the mouse is a poor model of the clinical situation.
